The LDL receptor plays a pivotal role in the clearance of proatherogenic lipoproteins, and LDL receptor deficiency may be the underlying cause of several primary and secondary dyslipidaemic conditions. Intervention strategies are often targeted to increase hepatic LDL receptor expression. It is difficult to quantitate hepatic LDL receptor activity and to monitor changes post-therapy. In order to avoid liver biopsy, human skin fibroblasts or circulating mononuclear cells have often been used as surrogate markers for the hepatic receptor. Fibroblasts, and particularly mononuclear cells, are relatively easy to isolate and can be stored for extensive lengths of time without significant loss of LDL receptor expression. Leucocytes or fibroblasts are normally probed with isotopically or gold-labelled LDL. However, the specific activity of the LDL conjugate is usually too low to enable accurate quantitation of differences, or changes, in LDL receptor expression. In this study, we describe an enhanced colloidal gold-labelling procedure for the detection of LDL receptor binding activity. The binding of colloidal gold-labelled chylomicron remnants to human hepatocytes (HepG2 cells) was compared with that of gold-conjugated LDL. Labelled remnants bound specifically to a cell surface protein with a molecular weight of approximately 130 kDa. Binding was blocked in the presence of unlabelled remnants, LDL, or antiserum specific to the LDL receptor. The binding of gold-labelled remnants was substantially greater than that of gold-labelled LDL. Compared with gold-labelled LDL, we found a much clearer demarcation of remnant binding with hepatocytes incubated in the presence or absence of sterols. Our observations suggest that, because of the greater affinity of the LDL receptor for lipoproteins containing apolipoprotein E, changes in LDL receptor expression might be more readily identified using gold-labelled remnants. We conclude that gold-conjugated chylomicron remnants might provide a useful means of detecting subtle changes in LDL receptor expression.
The liver is the primary organ responsible for the clearance of pro-atherogenic lipoproteins, which include intermediate-density and low-density lipoproteins (IDL and LDL, respectively) and chylomicron remnants. Several putative hepatic receptors are likely to be involved in the clearance of these three 'remnant' lipoproteins; however, significant attention has focused on the expression of the LDL receptor, because of its pivotal role in clearing cholesterol-rich lipoproteins from plasma and in maintaining cholesterol Correspondence: Dr John Mamo. E-mail: mamoj@health.curtin.edu.au homeostasis in vivo.I The LDL receptor is a multifunctional lipoprotein receptor because it has the capacity to facilitate internalization of LD L via recognition of apolipoprotein B100 and IDL and chylomicron remnants, via recognition of apolipoprotein E.1-3
Several laboratories have developed procedures for quantifying LDL receptor expression in vivo and in vitro; however, none of these methods seem sufficiently sensitive to discriminate between subjects with different levels of receptor expression.v" Generally, the interaction of lipoproteins with the LDL receptor has been studied by radiolabelling lipoproteins and then monitoring their clearance within a whole organism.P or in cell culture." Endogenous labelling of lipoproteins has included incorporation of radiolabelled cholesteryl esters, whereas the predominant technique for exogenous labelling has been to radioiodinate apolipoprotein B, a structural protein of chylomicron remnants which does not transfer between lipoproteins.P:" The radiolabelling of lipoproteins, particularly of IDL and chylomicron remnants, has often proved difficult because of poor lipoprotein recoveries, low concentrations of particles, labelling of non-B-apolipoproteins, exchange of the radiolabel, and potential changes in the biological properties of the particles following tagging.
In an effort to circumvent some of the difficulties associated with isotopic labelling, Roach et al. described a procedure in which LDL conjugated with colloidal gold was used to measure cell surface LDL receptor expression on human mononuclear cells.' Importantly, leucocyte LDL receptor expression appears to correlate with hepatic receptor levels, suggesting that mononuclear cells could be used as a surrogate marker of net clearance capacity within a whole organism.v" The colloidal gold-LDL approach has the advantages of being noninvasive, relatively simple and having the potential to be semi-automated. However, the procedure has not been widely adopted because the method appears to be insufficiently sensitive to detect subtle differences in receptor expression that might occur in subjects with moderate dyslipidaemia or in individuals receiving lipidlowering intervention therapy.
A number of laboratories have shown that the LDL receptor has substantially greater affinity for lipoproteins containing apolipoprotein E than for those that contain apolipoprotein BIOO alone.? Theoretically, the preferential binding of apolipoprotein E-containing lipoproteins might provide a mechanism for enhancing the sensitivity of the colloidal gold-labelled lipoprotein technique. Given the importance of obtaining a measure of LDL receptor expression, particularly in subjects with coronary artery disease, the aim of this study was to determine if colloidal gold-labelled apolipoprotein E-containing lipoproteins could be used to identify changes in hepatic LDL receptor expression. We present evidence that goldlabelled chylomicron remnants are suitable for the specific detection of the LDL receptor in human hepatocytes, and that changes in LDL Ann Clin Biochem 2000: 37 receptor expression are mirrored in the level of remnant binding.
METHODS

Cell cultures
Human hepatoma cells (HepG2) were grown under 5% CO 2 at 37°C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 12mgjmL penicillin, 16mgjmL gentamicin, 20mmoljL HEPES buffer, IOrnmol/L NaOH, 2mmoljL L-glutamine and 10% (vjv) foetal calf serum (FCS) (Life Technologies, Australia). Cells were subcultured and maintained as previously described.P Cells were grown to near confluence (80--90%; 2 days after seeding) and incubated in DMEM supplemented with 10% (vjv) FCS. FCS contains a full complement of serum lipoproteins, and cells were therefore sterol-loaded when grown in DMEM supplemented with 10% (vjv) FCS. In order to stimulate LDL receptor expression, cells were cultured for 1 day in the absence of exogenous sterols [DMEM supplemented with 10% (vjv) lipoprotein-deficient FCS].
Lipoprotein-deficient serum (LPDS) was prepared from FCS. 13 Briefly, FCS was adjusted to a final density of 1·215g/rnl, with potassium bromide and centrifuged at 38000 rpm for 40 h at 10°C in a Beckman Optima ultracentrifuge using a Beckman Ti60 rotor. Following removal of the lipoprotein fraction by aspiration, the infranatant was collected and dialysed at 4°C against 150mmol!L NaCI for 48-72h.
Isolation and conjugation of lipoproteins with colloidal gold
Human LDL (1,025< p < 1·050g/rnl.) and chylomicron remnants were isolated by sequential ultracentrifugation as previously described,14 then dialysed overnight against 50mmol/L EDTA (pH 8,0). Chylomicron remnants were generated in eviscerated rabbits following a bolus dose of chylomicrons from rats.'! Colloidal gold was prepared by the method of Frens.!' Lipoproteins (150ug of protein) were diluted to 0'5mL with water and 5mL of colloidal gold solution was rapidly added while vortexing. The conjugates were pelleted at 20000 g at 10°C for 20 min and the supernatant was removed by gentle aspiration. The lipoprotein conjugates were collected and combined, then sucrose was added to achieve a final concentration of 20% (w!v). The cellular protein concentration was measured by the method of Lowry et 01. 16 Lipoproteins labelJed with colloidal gold were stable for at least 6 months at -80°C.
Solubilization of liver cells and ligand blotting
Cultured HepG2 cells were washed extensively in phosphate-buffered saline (PBS) before being scraped from the flasks and resuspended in PBS. The cells were solubilized by incubation for 12 h in a solution of 1·5% (w/v) Triton X-IOO containing 50 mmol/L Tris-maleate (pH 6), 2 mmol/L CaCh, I mmol/L phenylmethylsulphonyl fluoride and 10mmol/L N-ethylmaleimide. Solubilized cell protein (100 mg) and rainbow molecular weight markers (Amersham Pharmacia Biotech, Amersham, UK) were separated by electrophoresis on 2-15% sodium dodecyl sulphate-polyacrylamide gradient gels at 30 rnA for 5 h, with water cooling. Separated proteins were electrotransferred at 45 V onto 0'45-JJm nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany) for 12 h. The nitrocelJulose membranes were cut into strips and incubated in buffer A [120mmol/L Tris, pH 8'0, 50mmol/L NaCl, 4mmoi/L CaCh, 40mgl ml bovine serum albumin (BSA)] for I h at 37°C with gentle agitation. The buffer was then replaced with lOml of buffer B (60mmol/L Tris, pH 8,0, 25 mmol/L NaCl, 2 mmol/L csci, 20 mg/ml, BSA) containing 20 JJg/mL colJoidal gold--chylomicron remnant conjugates. For competition studies, a lO-fold excess of un-labelJed chylomicron remnants or LOL receptor antibody (3,7 JJg/mL protein) was included in the incubation buffer containing gold--chylomicron remnant conjugates. The LOL receptor antibody is a polyclonal antibody that was raised in rabbits against a purified LOL receptor from bovine adrenal cortex.'? After the gold-ligand overlay, the nitrocelJulose strips were rinsed extensively with deionized water and dried; the bands were then scanned and quantified using a UMAX Vista S6E flatbed scanner.
RESULTS
Binding of chylomicron remnants to the LDL receptor
The conjugation of chylomicron remnants and LDL to gold particles was assessed using electron microscopy. Figure I depicts chylomicron remnants and LOL conjugated with COlloidal gold. The number of lipoprotein molecules that were bound to each colloidal gold particle differed significantly for the two lipoprotein types. Figure I(a) shows that one to Detection of LDL receptor by ligand blotting 473 three chylomicron remnants bound to each gold particle; for LOL, the number of particles per gold molecule was up to four times greater (see Fig. Ib ).
To assess LOL receptor expression in human hepatocytes, HepG2 cells were cultured and harvested. Electroblots of solubilized liver cells were probed with either 20 JJg/mL of colloidal gold-labelled chylomicron remnants or gold-LOL. Figure 2 shows that the binding of goldremnants and gold-LOL was specific, each identifying a single binding site with an apparent molecular weight of approximately 130 kOa on lanes containing liver cell protein extracts. The binding of colloidal gold-labelled chylomicron remnants (lane 2) was 2'4-fold higher than that of colloidal gold-labelled LOL (lane 3).
The interaction of gold--chylomicron remnant conjugates with the 130-kOa protein was examined in the presence of unlabelled lipoproteins in order to verify the specificity of binding. At a Io-fold excess of unlabelJed remnants, binding of gold-remnants to the 130-kOa protein was decreased by 90% (see Fig. 3 , lane 3) when compared with blots incubated with gold-remnants alone (see Fig. 3, lane 2) . Similarly, unlabelled LOL diminished the intensity of gold-remnant binding by approximately 80% (see Fig. 3, lane 4) . Evidence that the 130-kOa protein that bound gold--chylomicron remnants and gold-LOL represented the LOL receptor was provided by observations that a rabbit polyclonal LOL receptor antibody (3'7 JJg protein per mL) to the receptor displaced binding of gold--chylomicron remnants by more than 90% (see Fig. 3 , lane 5). The LOL receptor antibody used in this study has been shown to be highly specific for the human LOL receptor. I?
To explore whether binding of colloidal goldlabelled chylomicron remnants to the LOL receptor was sufficiently sensitive to identify changes in the plasma expression of the protein, we monitored the intensity of staining in HepG2 cells grown in the presence of complete serum or lipoprotein-deficient serum. The downregulation of LOL receptors in cells grown in the presence of cholesterol (OMEM containing 10% FCS) (see Fig. 4 , lane 3) was clearly indicated by a 72% reduction in the intensity of the LOL receptor band compared with cells incubated in the absence of cholesterol (OMEM containing LPOS) (see Fig. 4, lane 2) . In the presence of lO-fold excess of unlabelled remnants, the binding intensity of gold-labelled remnants was attenuated by 90% (see Fig. 4 , lane 4) 
. Colloidal gold-conjugated lipoproteins. Lipoproteins were isolated and conjugated to colloidal gold as described under 'Methods': (a) gold-conjugated chylomicron remnants; (h) gold-conjugated LDL. Bar r-UI I'm,
when compared with blots incubated with gold-remnants alone (see Fig. 4, lane 2) in sterol-deficient cells. Competitive binding of gold-labelled remnants to the LDL receptor in cells grown in media supplemented with Ann Clin Biochem 2000: 37 complete serum was also done in order to unequivocally demonstrate binding specificity. The 130-kDa protein band identified by goldlabelled remnants (see Fig. 4, lane 3) was reduced by 67% when HepG2 cell membrane proteins were co-incubated with a IO-fold excess of unlabelled chylomicron remnants (see Fig. 4, lane 5) . The binding of goldconjugated LOL to the LOL receptor in sterolloaded and sterol-deficient cells was also assessed. The binding of colloidal gold-LOL to the LOL receptor was decreased by 58% in cells grown in media supplemented with complete serum (see Fig. 4, lane 7) compared with cells grown in sterol-deficient media (see Fig. 4, lane 6) .
DISCUSSION
Remnant lipoproteins were collected from eviscerated rabbits given a large bolus dose of chylomicrons. The remnant isolates were apolipoprotein E-enriched (37% of total apolipoprotein content) and were homogeneous in size (40-70 nm). Remnant lipoproteins could be readily conjugated to colloidal gold; however, the association was somewhat different than for LOL. We found that there were, on average, up to fourfold fewer chylomicron remnants per gold particle compared with LOL (see Fig. I ).
Conjugation of lipoproteins to colloidal gold occurs by electrostatic surface adsorption due to the negative charge of the gold particles; thus the lower rates of remnant association with gold molecules may have been a consequence of steric hindrance, which would occur with larger lipoprotein particles. Nonetheless, binding of colloidal gold to chylomicron remnants was clearly lipoprotein-dependent, because incubation of cell protein extracts with free gold yielded no detectable bands on the electroblots (see Fig. 2 , lane 4). Binding of gold-chylomicron remnants to extracts of human hepatocytes was found to be specific, with only a single band being identified. The apparent molecular weight of the protein that bound colloidal gold-labelled remnants was approximately 130 kOa, and the rate of migration of the band was identical to that which bound gold-labelled LOL. Evidence that the 130-kOa band was the LOL receptor was indicated by competition studies in which binding to chylomicron remnants and to LDL was significantly attenuated in the presence of unlabelled lipoproteins. Moreover, in the presence of antiserum specific for the LDL receptor, binding of gold-remnants was almost completely abolished. Collectively, the data suggest that gold-remnants were associating with the LDL receptor. At equal protein concentrations, binding of the gold-chylomicron remnants to detect the LDL receptor appeared to be several-fold greater than for gold-conjugated LDL. Our observations were consistent with the greater number of gold particles per unit of lipoproteins, compared with LDL. The sensitivity of remnant detection might have been even further increased by increasing the number of chylomicron remnants in the incubation, although this was not specifically explored in this study. Chylomicron remnants are substantially larger than LDL and contain less protein mass per particle. At the protein concentrations used in this study, the ratio of AIIII Clin Biochem 2000: 37 chylomicron remnant particles to LDL particles was approximately I: 100. If the cell extracts were incubated with similar numbers of either goldremnants or gold-LDL conjugates, the difference in binding intensity between the two lipoproteins may have been substantially greater.
We explored whether changes in receptor expression induced by sterol deprivation could be identified by the intensity of gold-remnant labelling (see Fig. 4 ). The binding intensity of gold-labelled chylomicron remnants and goldlabelled LDL to the LDL receptor on nitrocellulose membranes was significantly more pronounced in cells when the LDL receptor had been stimulated (cells grown in lipoproteindeficient serum) compared with cells in which it had been depressed (complete serum). Increasing the sterol content of cells has been previously demonstrated to downregulate the LDL receptor in human fibroblasts and hepatocytes, as measured by the binding of radiolabelled LDL.1J,IH Collectively, the results of this study show that chylomicron remnants labelled with colloidal 97kDa . . . 66kDa . . 220 kDa . . . gold bind exclusively to the LDL receptor of human hepatocytes and that changes in receptor expression appear to be readily identified by changes in the intensity of staining. Colloidal gold-remnant conjugates are relatively simple to prepare, are safe and inexpensive and can be stored for long periods of time. The binding of gold-conjugated chylomicron remnants to the LDL receptor on nitrocellulose membranes can be visualized and quantified as a single, intense red colour within 5 10min of incubation. We conclude that colloidal gold-labelled chylomicron remnants may be useful for quantification of LDL receptor expression.
